The amount of the deal was not disclosed. With this investment, genae further expands its activities in Japan and in the Asia Pacific region and obtained a call option to acquire all remaining shares of Meditrix.
Led by Ichiro Oshiba, President, Meditrix is a full service CRO with focus on clinical studies of medical devices in pre- and post-marketing stage in Japan. In such activities, the company is contributing to collecting clinical data by utilizing its trained resources and its proprietary Electronic Data Capture system, tailored for the Japanese market.
Meditrix operates from its HQ in Tokyo and from branch offices in Osaka and Fukuoka.